Treatment with the drug tocilizumab has been shown to reduce the risk of death among hospitalized patients with severe COVID-19.<br />Tocilizumab cuts the risk of death by about 30%, according to a study published Tuesday.<br />The medication, which also goes by the name Actmera is primarily used to treat rheumatoid arthritis.<br />The medication is an immunosuppressive drug designed to reduce inflammation.<br />It also works to suppress interleukin 6, a type of protein involved in the inflammatory process in a number of diseases, including COVID-19.
